Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Wilderness Environ Med ; 34(2): 214-217, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36868886

RESUMEN

Systemic symptoms resulting from exposure to members of the Lepidoptera order, such as moths, butterflies, and caterpillars, are known as lepidopterism. Most cases of lepidopterism are mild and result from dermal exposure to urticating hairs; ingestion is less common and generally more medically significant because the hairs may get embedded in the patient's mouth, hypopharynx, or esophagus, leading to dysphagia, drooling, edema, and possible airway obstruction. In previous cases of symptomatic caterpillar ingestion reported in the literature, extensive efforts, including direct laryngoscopy, esophagoscopy, and bronchoscopy, were undertaken to remove these hairs. We review the case of a 19-mo-old previously healthy male infant who presented to the emergency department with vomiting and inconsolability after ingesting half of a woolly bear caterpillar (Pyrrharctia isabella). His initial examination was notable for embedded hairs in his lips, oral mucosa, and right tonsillar pillar. The patient underwent a bedside flexible laryngoscopy, which revealed a single hair embedded in the epiglottis, without significant edema. He was stable from a respiratory standpoint and, thus, was admitted for observation and IV dexamethasone without any attempt to remove the hairs. He was discharged in good condition after 48 h; at a follow-up visit 1 wk later, no remaining hairs were visible. This case demonstrates that lepidopterism secondary to caterpillar ingestion is amenable to conservative management and does not require routine removal of urticating hairs in patients who do not show signs of airway distress.


Asunto(s)
Mariposas Diurnas , Mariposas Nocturnas , Animales , Masculino , Edema , Ingestión de Alimentos , Larva
2.
Pediatrics ; 148(5)2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34607934

RESUMEN

BACKGROUND AND OBJECTIVES: In 2008, over-the-counter cough and cold medications (CCMs) underwent labeling changes in response to safety concerns, including fatalities, reported in children exposed to CCMs. The objective of this study is to describe fatalities associated with exposures to CCMs in children <12 years old that were detected by a safety surveillance system from 2008 to 2016. METHODS: Fatalities in children <12 years old that occurred between 2008 and 2016 associated with oral exposure to one or more CCMs were identified by the Pediatric Cough and Cold Safety Surveillance System. An expert panel reviewed all cases to determine the causal relationship between the exposure and death, if the intent of exposure was therapeutic, and if the dose was supratherapeutic. Other contributing factors related to the child's death were also identified as part of a root cause analysis. RESULTS: Of the 180 eligible fatalities captured during the study period, 40 were judged by the expert panel to be either related or potentially related to the CCM. Of these, the majority (n = 24; 60.0%) occurred in children <2 years old and involved nontherapeutic intent (n = 22; 55.0%). The most frequently involved index ingredient was diphenhydramine (n = 28; 70.0%). In 6 cases (n = 6; 15.0%), the CCM was administered to murder the child. In another 7 cases (n = 7; 17.5%), death followed the intentional use of the CCM to sedate the child. CONCLUSIONS: Pediatric fatalities associated with CCMs occurred primarily in young children after deliberate medication administration with nontherapeutic intent by a caregiver.


Asunto(s)
Antitusígenos/envenenamiento , Medicamentos sin Prescripción/envenenamiento , Antitusígenos/administración & dosificación , Bromofeniramina/envenenamiento , Niño , Preescolar , Clorfeniramina/envenenamiento , Dextrometorfano/envenenamiento , Difenhidramina/administración & dosificación , Difenhidramina/envenenamiento , Doxilamina/envenenamiento , Etiquetado de Medicamentos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/mortalidad , Femenino , Guaifenesina/envenenamiento , Homicidio/estadística & datos numéricos , Humanos , Lactante , Masculino , Medicamentos sin Prescripción/administración & dosificación , Fenilefrina/envenenamiento , Seudoefedrina/envenenamiento
3.
J Emerg Med ; 57(4): 523-526, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31492593

RESUMEN

BACKGROUND: Black widow spider (Latrodectus spp) envenomation represents the most medically significant spider envenomation in the United States, prompting more than 2500 calls to poison centers annually. The female spider, which is responsible for symptomatic envenomations, is classically described as a shiny black spider with a red hourglass-shaped marking on the ventral abdomen. Clinical features of envenomation include painful muscle cramping, abdominal pain, and autonomic disturbances, such as tachycardia, hypertension, and diaphoresis. "Latrodectus facies" or "facies latrodectismica" is an additional distinctive but rarely described clinical finding characterized by periorbital edema, lacrimation, and blepharospasm. CASE REPORT: A 6-year-old female developed the typical clinical features of Latrodectus envenomation after being found in bed with a Western black widow spider (Latrodectus hesperus) with no ventral marking. She initially improved with opioid analgesia, but 6 h later her symptoms worsened again, and concurrent with this worsening she developed Latrodectus facies. She received additional opioid analgesia and all her symptoms resolved within 24 h. Her mother provided informed and written consent for the acquisition and publication of the facial photographs presented. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: A high degree of clinical suspicion is necessary to correctly diagnose Latrodectus envenomation, especially when the spider escapes unnoticed or in young children in whom the bite is not witnessed. To our knowledge, Latrodectus facies has not been reported previously in a young child, and recognition of this finding will aid clinicians in limiting unnecessary interventions and administering appropriate therapy.


Asunto(s)
Araña Viuda Negra/patogenicidad , Cara/anomalías , Venenos de Araña/efectos adversos , Animales , Antivenenos/uso terapéutico , Niño , Servicio de Urgencia en Hospital/organización & administración , Cara/fisiopatología , Femenino , Dolor en el Flanco/etiología , Humanos , Manejo del Dolor/métodos , Manejo del Dolor/normas , Venenos de Araña/metabolismo
5.
J Adolesc Health ; 63(2): 239-241, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29609916

RESUMEN

PURPOSE: Approximately 6%-8% of U.S. adolescents are daily/past-month users of marijuana. However, survey data may not reliably reflect the impact of legalization on adolescents. The objective was to evaluate the impact of marijuana legalization on adolescent emergency department and urgent cares visits to a children's hospital in Colorado, a state that has allowed both medical and recreational marijuana. METHODS: Retrospective review of marijuana-related visits by International Classification of Diseases codes and urine drug screens, from 2005 through 2015, for patients ≥ 13 and < 21 years old. RESULTS: From 2005 to 2015, 4,202 marijuana-related visits were identified. Behavioral health evaluation was obtained for 2,813 (67%); a psychiatric diagnosis was made for the majority (71%) of these visits. Coingestants were common; the most common was ethanol (12%). Marijuana-related visits increased from 1.8 per 1,000 visits in 2009 to 4.9 in 2015. (p = < .0001) CONCLUSIONS: Despite national survey data suggesting no appreciable difference in adolescent marijuana use, our data demonstrate a significant increase in adolescent marijuana-associated emergency department and urgent cares visits in Colorado.


Asunto(s)
Atención Ambulatoria/estadística & datos numéricos , Servicio de Urgencia en Hospital/estadística & datos numéricos , Abuso de Marihuana/epidemiología , Abuso de Marihuana/psicología , Uso de la Marihuana/psicología , Adolescente , Adulto , Cannabis/efectos adversos , Colorado/epidemiología , Femenino , Humanos , Masculino , Uso de la Marihuana/legislación & jurisprudencia , Estudios Retrospectivos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...